ClinicalTrials.Veeva

Menu
F

Florida Retina Consultants | Lakeland, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Aflibercept
Runcaciguat
ABP 938
KSI-301
Tonabersat
YD312
Abicipar Pegol
Triamcinolone Acetonide
Bevacizumab
Pemafibrate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 24 total trials

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 y...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Biological: Aflibercept (EYLEA®)
Genetic: ABBV-RGX-314 Dose 2

Phase 2b, randomized, double-masked, parallel-group, active-controlled, multicenter, 36-week study designed to assess the safety and efficacy of supr...

Active, not recruiting
Neovascular Age-related Macular Degeneration
Drug: Aflibercept
Drug: CLS-AX

Trial sponsors

Jaeb Center for Health Research logo
AbbVie logo
Allergan logo
Amgen logo
Bayer logo
Boehringer Ingelheim logo
C
Kodiak Sciences logo
Lilly logo
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems